Innovative approaches in diagnosis of emerging/re-emerging infectious diseases

Molecular diagnostics continues to evolve terribly quickly, and its impact within the designation of infectious diseases is plain. Molecular tools have a crucial role in discovering and characterizing many rising infectious agents and have currently become the gold commonplace for the designation of infectious diseases caused by fastidious or uncultivated agents. Multiple challenges still stay for the widespread use of efficient, validated, and commercially accessible molecular tools. Machine-controlled instruments capable of sample process and multiplex macromolecule amplification and post amplification analysis have already been approved by the North American nation Food and Drug Administration (FDA) to be used within the clinical setting. Nano biotechnology is commencing to impact laboratory medical specialty within the clinical setting.

    Related Conference of Innovative approaches in diagnosis of emerging/re-emerging infectious diseases

    November 21-22, 2024

    7th Pathology and Infectious Disease Conference

    Dubai, UAE
    November 28-29, 2024

    20th World Congress on Infection Prevention and Control

    Paris, France
    March 13-14, 2025

    9th International Conference on Rare Diseases

    Prague, Czech Republic
    March 17-18, 2025

    12th International Congress on Infectious Diseases

    Berlin, Germany
    April 14-15, 2025

    15th European Epidemiology and Public Health Congress

    Budapest, Hungary
    June 02-03, 2025

    17th Euro-Global Conference on Infectious Diseases

    Amsterdam, Netherlands
    June 02-03, 2025

    14th World Congress on Rare Diseases and Orphan Drugs

    Amsterdam, Netherlands

    Innovative approaches in diagnosis of emerging/re-emerging infectious diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in